Status:
COMPLETED
Roflumilast In-Vitro Basophil Release
Lead Sponsor:
Creighton University
Collaborating Sponsors:
Takeda
Conditions:
Allergy
Asthma
Eligibility:
All Genders
19-65 years
Brief Summary
This study is looking for allergic asthmatics. Lung and allergy testing will be done to verify. If qualified, blood will be drawn for laboratory studies.
Detailed Description
Non-smoking allergic asthmatics will be verified using pulmonary function, skin prick testing, exhaled nitric oxide and serum IgE. If qualified, blood will be drawn, treated with study medication and ...
Eligibility Criteria
Inclusion
- Age 19 and above Allergic Asthma Serum IgE greater than 30iu/ml Exhaled Nitric Oxide greater than 17ppb
Exclusion
- smoking history
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00613587
Start Date
August 1 2007
End Date
January 1 2010
Last Update
October 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Creighton University Medical Center
Omaha, Nebraska, United States, 68131